Title: The Preliminary Study on Safety of Using Mangosteen Peel Extract as Natural Herbs
Authors: Lanny Sunarjo, Oedijani, Suharti, Henry Setyawan Susanto
DOI: https://dx.doi.org/10.18535/jmscr/v5i7.92
Abstract
Background: The properties of mangosteen skin as anti-inflammatory have been described by many researchers both in vitro and in vivo. Over the past few years, mangosteen peel extract is used as a natural herbal remedy either orally or topically. However, the potential toxicity of extracts and formulations containing mangosteen peels is still a matter of little concern.
Objective: To prove that mangosteen skin extract is safe to use as natural herbal medicine.
Methods: Experiments with laboratory tests of microbiological tests and acute toxicity tests with samples of 30 Balb / C mice aged 8-10 weeks weight 25-35 g, divided into 6 groups in which 5 groups of intervention (giving mangosteen skin extract) with different dose (5, 50, 300, 2000 and 5000 mg / kgBB) and 1 control group. Parameters observed included weight, motor activity, salivation, respiration, defecation, urination, piloerection every day for 14 days while the observed organ was liver. Behavioral data and organ test results were used to evaluate the toxic effects of mangosteen skin extract. Data was analyzed with ANOVA and Post Hoc Test.
Results: Most subjects' mean body weight from day 0 to day 14 tended to stabilize with a slight increase or decrease of less than 1%. The results of observation for 14 days after the intervention to each group there was no death and no effect on the motor system, saliva, respiration, defecation, urination and piloerection and did not happen itch allergies. Based on Post Hoc Test (LSD), there was no significant difference in mean liver weight group with highest dose (5000 mg / kgBB) and control group.
Conclusion: Extract of mangosteen skin with dosage ≤ 5000 mg/kg BW is not toxic and safe to use as natural herbal medicine.
Keywords: peel of Mangosteen extract, toxicity, natural herbal medicine .
References
1. Bunyong, R., Chaijaroenkul, W., Plengsuriyakarn, T. & Na-Bangchang, K. 2014. Antimalarial activity and toxicity of Garcinia mangostana Linn. Asian Pacific journal of tropical medicine, 7, 693-698.
2. Chaivisuthangkura, A., Malaikaew, Y., Chaovanalikit, A., Jaratrungtawee, A., Panseeta, P., Ratananukul, P. & Suksamrarn, S. 2009. Prenylated xanthone composition of Garcinia mangostana (mangosteen) fruit hull. Chromatographia, 69(3-4), 315-318.
3. Cui, J., Hu, W., Cai, Z., Liu, Y., Li, S., Tao, W. & Xiang, H. 2010. New medicinal properties of mangostins: Analgesic activity and pharmacological characteri-zation of active ingredients from the fruit hull of Garcinia mangostana L. Pharmacology Biochemistry and Behavior, 95(2), 166-172.
4. Hutadilok-Towatana, N., Reanmongkol, W., Wattanapiromsakul, C. & Bunkrongcheap, R. 2010. Acute and subchronic toxicity evaluation of the hydroethanolic extract of mangosteen pericarp. Journal of Medicinal Plants Research, 4, 969-974.
5. Lei, J., Huo, X., Duan, W., Xu, Q., Li, R., Ma, J., Li, X., Han, L., Li, W. & Sun, H. 2014. α-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion. Cancer letters, 347 (1), 129-138.
6. Obolskiy, D., Pischel, I., Siriwatan-ametanon, N. & Heinrich, M. 2009. Garcinia mangostana L.: a phytochemical and pharmacological review. Phytotherapy research, 23 (8), 1047-1065.
7. Ozyurt, D., Demirata, B. & Apak, R. 2007. Determination of total antioxidant capacity by a new spectrophotometric method based on Ce (IV) reducing capacity measurement. Talanta, 71 (3), 1155-1165.
8. Patel, D., Kumar, R., Laloo, D. & Hemalatha, S. 2012. Natural medicines from plant source used for therapy of diabetes mellitus: An overview of its pharmacological aspects. Asian Pacific Journal of Tropical Disease, 2 (3), 239-250.
9. Pedraza-Chaverri, J., Cárdenas-Rodríguez, N., Orozco-Ibarra, M. & Pérez-Rojas, J. M. 2008. Medicinal properties of mangosteen (Garcinia mangostana). Food and Chemical Toxicology, 46 (10), 3227-3239.
10. Rassameemasmaung, S., Sirikulsathean, A., Amornchat, C., Maungmingsook, P., Rojanapanthu, P. & Gritsanaphan, W. 2008. Topical application of Garcinia mangostana L. pericarp gel as an adjunct to periodontal treatment. Complementary therapies in medicine, 16 (5), 262-267.
11. Shan, T., Ma, Q., Guo, K., Liu, J., Li, W., Wang, F. & Wu, E. 2011. Xanthones from Mangosteen extracts as natural chemopreventive agents: potential anticancer drugs. Current molecular medicine, 11 (8), 666.
12. Sornprasit, A., Sripiyarattanakul, K., Chuay-Yim, P. & Tanakittihum, P. 1987. Preliminary toxicological study of mangostin. Songklanakarin J Sci Technol, 9, 51-57.
13. Vishnu Priya, V., Jainu, M., Mohan, S. K., Karthik, B., Saraswathi, P. & Chandra Sada, G. 2010. Toxicity study of Garcinia mangostana Linn. pericarp extract in rats. Asian J Exp Biol Sci, 1, 633-637.
14. Walker, E. B. 2007. HPLC analysis of selected xanthones in mangosteen fruit. Journal of separation science, 30 (9), 1229-1234.
15. Wong, L. P. & Klemmer, P. J. 2008. Severe lactic acidosis associated with juice of the mangosteen fruit Garcinia mangostana. American Journal of Kidney Diseases, 51, 829-833.
16. Zhao, Y., Tang, G., Tang, Q., Zhang, J., Hou, Y., Cai, E., Liu, S., Lei, D., Zhang, L. & Wang, S. 2016. A Method of Effectively Improved α-Mangostin Bioavailability. European journal of drug metabolism and pharmacokinetics, 41, 605-613.